Vineet Laboratories Limited (VINEETLAB) — corporate announcements

All
Important
Financial Update
Fund Raise
Board Meeting
Dividend/Bonus
JV/Acquisition
Investor Meet
Insider Trade
Pledging
Others

Download our app

Get the best experience on mobile

Join 5K+ users on Alpha Tribe

Vineet Laboratories Limited

$VINEETLAB

Incorporated in 2003, Vineet Laboratories Ltd is in designing, developing, manufacturing of API Intermediates and Bulk Drugs

Pharmaceuticals

29-08-2026 | 07:00 pm

Vineet Laboratories' board has approved its financial results for the quarter and year ended March 31. The company turned profitable (0.13 Cr PBT) from a significant loss. Share issuance brought 29.08 Cr, boosting equity and cash to 16.70 Cr. Long-term borrowings decreased to 35.29 Cr.

PDF

25-08-2026 | 07:52 pm

Vineet Labs' board met, approving its audited standalone financial results for Q4 & FY ended March 31, 2026. FY26 net sales hit ₹58.40 Cr with a profit of ₹1.11 Cr & EPS of ₹1.00. Long-term borrowings decreased to ₹35.29 Cr from ₹39.09 Cr.

PDF

25-08-2026 | 07:35 pm

Vineet Labs' board approved audited standalone financial results for the fourth quarter and full year ended March 31, 2026. FY26 net sales stood at ₹58.40 Cr, with a profit of ₹1.11 Cr.

PDF

14-08-2026 | 07:04 pm

Please find the attached Monitoring Agency Report issued by CRISIL rating Limited for quarter ended June 30, 2026

PDF

30-07-2026 | 11:18 pm

Vineet Laboratories Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__

PDF

Download our app

Vineet Laboratories Limited

Vineet Laboratories Limited

General Updates

Vineet Laboratories Limited

Outcome of Board Meeting

Vineet Laboratories Limited

Outcome of Board Meeting

Vineet Laboratories Limited

Monitoring Agency Report

Vineet Laboratories Limited

Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter